Krishna Institute of Medical Sciences Performance
- Today's Low
- ₹744
- Today's High
- ₹770
- 52 Week Low
- ₹576
- 52 Week High
- ₹798
- Open Price₹770
- Previous Close₹764
- Volume233,184
- 50 DMA₹700.46
- 100 DMA₹685.52
- 200 DMA₹674.26
Krishna Institute of Medical Sciences Chart
Investment Returns
- Over 1 Month + 16.22%
- Over 3 Month + 2.85%
- Over 6 Month + 11.55%
- Over 1 Year + 12.47%
Smart Investing Starts Here Start SIP with Krishna Institute of Medical Sciences for Steady Growth!
Krishna Institute of Medical Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 125.4
- PEG Ratio
- -3.4
- Market Cap Cr
- 30,283
- P/B Ratio
- 13
- Average True Range
- 28.21
- EPS
- 6.2
- Dividend Yield
- 0
- MACD Signal
- 22.58
- RSI
- 59.04
- MFI
- 78.3
Latest Stock News Updates
Healthcare Facilities company Krishna Institute of Medical Sciences announced Q4FY26 & FY26 results Q4FY26 Consolidated Financial Highlights: Consolidated Revenue from Operations of Rs 1,075 crore, a growth of 34.8% on YoY and 7.7% on QoQ basis. Consolidated EBITDA (Pre-INDAS) of Rs 197 crore, there is no growth on YoY basis and a growth of 1.8% on QoQ basis. Consolidated EBITDA (Pre-INDAS and excluding Other Income) of Rs 187 crore, a degrowth of 2.7 % on YoY and a degrowth of 0.6% on QoQ basis. Q4FY26 Standalone Financial Highlights: Total Revenue of Rs 1,084 crore, a growth of 35.3% on YoY and 8.1% on QoQ basis. EBITDA of Rs 216 crore, a growth of 6.8% on YoY and 5.9% on QoQ basis. EBITDA margin at 19.9% vs. 25.3% in Q4FY25 and 20.4% in Q3FY26. PAT at Rs 33 crore in Q4FY26 against Rs 106 crore and Rs 52 crore in Q4FY25 and Q3FY26 respectively. Cash and Cash Equivalents (includes Cash, Bank balance, Deposits with maturity less than 12 months and Investment in Mutual funds) at Rs 90 crore as on 31st March 2026. FY26 Standalone Financial Highlights: Total revenue of Rs 3,931 crore, a growth of 28.2% on YoY basis. EBITDA of Rs 828 crore, a growth of 1.6% on YoY basis. EBITDA margin at 21.1 % vs. 26.6% in FY25. PAT at Rs 242 crore Vs Rs 415 crore in FY25. Consolidated EPS for FY26 of Rs 6.03, a degrowth of 37.2% on YoY basis. Business Highlights: Q4FY26 Updates: ARPOB grew by 13.7% and 1.7% on a YoY and QoQ basis, respectively. ARPP grew by 14% and 3.5% on a YoY and QoQ basis, respectively. FY26 Updates: ARPOB grew by 14% on a YoY basis. ARPP grew by 11.4% on a YoY basis. IP & OP Volume grew by 15.4% and 25.4%, respectively on a YoY basis. Bhaskara Rao, CMD, KIMS Hospitals, said: FY26 has been a year of accomplishments for us. Four new units across Bengaluru, Kerala and Thane have shown progress in the limited time of their operations. The new doctor’s additions to these facilities and the existing ones have reinforced the trust the clinicians have in the KIMS Brand and its quest to provide best clinical outcomes at affordable prices. We look forward to FY27 to fulfil the targets we have set for ourselves. Result PDF
- Trendlyne
- 1 week ago
The planning and statistics minister breathed his last at the Krishna Institute of Medical Sciences in Bengaluru
- Business Line
- 2 weeks 1 day ago
Equirus Securities reckon that healthcare sector delivered a 15.5 per cent revenue CAGR and a 25 per cent Ebitda CAGR between FY20 and FY25
- Business Standard
- 1 month 2 weeks ago
Krishna Institute of Medical Sciences Financials
Krishna Institute of Medical Sciences Technicals
EMA & SMA
- Bearish Moving Average 2
- Bullish Moving Average 14
- 20 Day
- ₹730.94
- 50 Day
- ₹700.46
- 100 Day
- ₹685.52
- 200 Day
- ₹674.26
Resistance and Support
- R3 795.72
- R2 782.83
- R1 769.82
- S1 743.92
- S2 731.03
- S3 718.02
Krishna Institute of Medical Sciences Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-05-15 | Audited Results | |
| 2026-03-11 | Rights Issue & Others | Inter-alia, to consider 1. Proposal for raising of funds by way of issuance of equity shares, in one or more tranches or rights issue or through any other permissible mode. 2. Other business matters. alia, to consider and approve raising of funds by way of issuance of Non-Convertible Debentures (NCDs), aggregating to Rs. 300 Crores in one or more tranches over a period of time. |
| 2026-02-06 | Quarterly Results | |
| 2025-11-07 | Quarterly Results | |
| 2025-08-06 | Quarterly Results |
About Krishna Institute of Medical Sciences
- NSE Symbol
- KIMS
- BSE Symbol
- 543308
- Chairman & Managing Director
- Dr. Bhaskara Rao Bollineni
- ISIN
- INE967H01025
Similar Stocks to Krishna Institute of Medical Sciences
Popular Stocks
Krishna Institute of Medical Sciences FAQs
Krishna Institute of Medical Sciences share price is ₹756 As on 26 May, 2026 | 02:27
The Market Cap of Krishna Institute of Medical Sciences is ₹30282.5 Cr As on 26 May, 2026 | 02:27
The P/E ratio of Krishna Institute of Medical Sciences is 125.4 As on 26 May, 2026 | 02:27
The PB ratio of Krishna Institute of Medical Sciences is 13 As on 26 May, 2026 | 02:27
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.